Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THE HEPDEP II STUDY
NCT00357045Phase 4Completed
- Sponsor
- VA Portland Healthcare System
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of paroxetine in major depressive disorder (MDD), sponsored by VA Portland Healthcare System. Status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00357045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357045.